Related Experiment Video
Updated: Mar 2, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Impella percutaneous left ventricular assist device for severe acute ischaemic mitral regurgitation as a bridge to
Bilal Jalil1, Karim El-Kersh1, Jarrod Frizzell2
1Deratment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Louisville, Louisville, Kentucky, USA.
Abstract:
Ischaemic papillary muscle rupture causing acute severe mitral regurgitation (MR) has a dramatic presentation and a very high mortality. Emergent surgical repair improves outcomes, which necessitates robust preoperative stabilisation. Here we discuss a patient with cardiogenic shock with an acute severe MR that was deemed very high risk for emergent valve replacement due to haemodynamic instability and respiratory failure. A percutaneous left ventricular assist device Impella 2.5 (Abiomed, Danvers, MA) drastically improved clinical status, and the patient underwent a successful surgical mitral valve replacement soon after placement of the temporary assist device. Our case highlights that percutaneous ventricular assist devices may help to stabilise patients with severe acute ischaemic MR, and it can serve as a bridge to surgery in high risk patients.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation III: Medical Management

